By Phil Hoekstra, PhD | Founder, Thermoscan
An examination of infrared breast imaging, its scientific foundations, technological evolution, and potential contribution to comprehensive breast health assessment.
Looking Beyond the Structure of Breast Cancer
For more than five decades, I have worked in the field of medical infrared imaging, with particular attention to breast cancer. During that time, I have witnessed remarkable technological advances, changing scientific perspectives, and continuing debate over thermography’s appropriate place in breast health.One principle has remained central to my work: Breast cancer is not exclusively a structural disease. It is also associated with physiological changes involving blood circulation, vascular development, and tissue metabolism.
Mammography, ultrasound, and magnetic resonance imaging provide essential anatomical information. Infrared thermography approaches the breast differently. Rather than visualizing a tumor directly, it measures temperature patterns at the skin’s surface that may reflect underlying physiological activity.
Understanding this distinction is fundamental to understanding both the possibilities and limitations of thermal imaging.
The Origins of Breast Thermography
The history of breast thermography extends to the late
1950s, when Dr. Raymond Lawson, working at
At the time, the prevailing explanation was that malignant cells generated excess heat through accelerated metabolism. Subsequent investigation suggested that metabolism alone could not adequately explain these observations.
Researchers increasingly examined the vascular environment surrounding developing tumors.
My own introduction to infrared technology began through my father’s work developing infrared systems for satellite observation and other advanced applications during the 1960s. I founded Thermoscan in 1972 to investigate medical applications of this technology, particularly breast cancer assessment.
Our earliest equipment was cumbersome, analog, and limited in precision. Nevertheless, it introduced an important possibility: measuring physiological information that conventional anatomical imaging did not directly capture.
Understanding the Vascular Connection
Cancer development frequently involves angiogenesis, the formation of new blood vessels that support tumor growth. These newly formed vessels can exhibit abnormal architecture, altered regulation, and increased permeability. Tumor-associated signaling molecules, including nitric oxide, may also influence regional blood flow through vasodilation. Together, these processes can contribute to changes in surface temperature.Modern infrared cameras measure emitted infrared radiation and translate those measurements into quantitative thermal information. Unlike X-ray imaging, the process does not involve ionizing radiation. It also requires no breast compression or intravenous contrast.
However, elevated temperature does not automatically indicate malignancy. Inflammation, infection, hormonal influences, previous surgery, and other benign conditions can produce thermal abnormalities.
The clinical challenge is not simply identifying heat. It is determining whether a measured thermal pattern has meaningful diagnostic significance.
What Clinical Research Has Demonstrated
An important investigation was published in The Breast Journal in 1998 by J.R. Keyserlingk and colleagues. The researchers retrospectively evaluated 100 consecutive patients with confirmed ductal carcinoma in situ or stage I and II breast cancer, comparing clinical examination, mammography, and high-resolution digital infrared imaging.
Selected findings from the 1998 study: abnormal infrared findings in 83% of cancer cases; 85% sensitivity for mammography when equivocal findings were included; and 95% detection when mammography and infrared imaging were combined.
Notably, 10 of 15 women whose mammograms were classified as nonspecific demonstrated abnormal infrared findings.
The researchers also reported abnormal thermograms in 19% of a separate group of 100 women whose biopsies proved benign.
These results suggested that infrared imaging might provide supplementary physiological information in selected diagnostic circumstances.
However, the study was retrospective, involved patients already known to have cancer, and did not establish performance in a general screening population.
The investigators explicitly recommended prospective, controlled multicenter research and cautioned against extrapolating their findings to routine screening. That distinction remains essential.
From Colorful Images to Quantitative Analysis
One of the most important technological developments has been the transition from visually interpreted thermal photographs to radiometric digital imaging. Radiometric cameras assign measurable temperature information to individual image pixels, allowing comparisons between anatomical regions.
At Thermoscan, our work has emphasized analytical evaluation rather than reliance on color patterns alone. This involves examining vascular asymmetry, localized temperature differences, unusual thermal distributions, and changes observed across serial examinations.
Appropriate equipment, environmental controls, patient preparation, standardized imaging procedures, and qualified analysis are critical. Even sophisticated thermal measurements cannot independently establish whether cancer is present. A suspicious finding requires evaluation through established clinical and diagnostic pathways.
The Question of Treatment Monitoring
Another area of interest involves observing physiological changes during cancer treatment. Because therapies can influence tumor vascularity and regional circulation, serial thermography has been investigated as a possible method of tracking treatment-associated changes.
In principle, these measurements could contribute information about biological responses occurring before obvious structural changes become apparent. Nevertheless, determining whether thermal changes reliably predict treatment effectiveness requires stronger clinical validation.
Thermography should not independently guide decisions to continue, modify, or discontinue cancer treatment.
Defining the Appropriate Role in Women’s Breast Health
I believe the most productive discussion about breast thermography begins by recognizing what the technology actually measures. It is a physiological imaging method, not a direct anatomical examination or a definitive cancer test.
Current evidence does not support using thermography as a replacement for mammography or other recommended breast screening. The FDA has also warned against promoting thermography as an alternative to mammography.
For women, particularly those with dense breast tissue, uncertain imaging findings, or elevated cancer risk, established supplemental imaging options should be discussed with their healthcare professionals.
The potential value of infrared imaging remains a legitimate subject for carefully designed research, including investigations of vascular physiology, longitudinal thermal patterns, and treatment-associated changes. After decades in this field, my conviction is that technological innovation must be accompanied by rigorous measurement, appropriate interpretation, and honest clinical validation.
The future of breast imaging should not be framed as a competition between technologies, but as a scientific effort to understand which measurements genuinely improve patient care.
Research Reference
Keyserlingk, J. R., Ahlgren, P. D., Yu, E., & Belliveau, N. (1998). Infrared imaging of the breast: Initial reappraisal using high-resolution digital technology in 100 successive cases of stage I and II breast cancer. The Breast Journal, 4(4).









.jpeg)



.jpeg)
















